Target intelligence / Profile preview

Bacterial DNA and Protozoal DNA

Molecular classification
Nucleic acid, Genetic material, Other
01

Overview

Bacterial and protozoal DNA refers to the deoxyribonucleic acid molecules that carry genetic information in bacterial and protozoan cells[1][2][3]. Bacterial DNA is typically a single, circular DNA molecule located in the cytoplasm, while protozoal DNA is located within a membrane-bound nucleus (or nuclei, in the case of ciliates), stored in linear chromosomes[2][3]. These DNA molecules encode genes essential for replication, cell structure, metabolism, and pathogenicity. Many antibiotics and antiprotozoal drugs act by targeting microbial DNA or the enzymes involved in its replication, transcription, or repair; however, "Bacterial/Protozoal DNA" itself is not generally considered a specific therapeutic target in the sense of a protein receptor or enzyme. Rather, it is a general substrate for DNA-acting drugs, and thus is too broad and unspecific a target term for drug databases or precise therapeutic targeting[1][2][3]. The identification of "Bacterial/Protozoal DNA" as a therapeutic target is imprecise, as most drugs actually target specific DNA-processing enzymes (e.g., gyrase, polymerase) rather than DNA itself.

Other names
Deoxyribonucleic acid of bacteriaDeoxyribonucleic acid of protozoaMicrobial DNA
02

Mechanism of action

Inhibition of DNA gyrase/topoisomerase (e.g., quinolones); DNA strand breakage after reduction (e.g., nitroimidazoles); Inhibition of DNA-dependent RNA polymerase (e.g., rifamycins); Inhibition of nucleotide synthesis (e.g., sulfonamides, indirectly)

03

Biological functions

Storage of hereditary informationTemplate for RNA synthesis (transcription)Template for DNA replicationRegulation of gene expressionCell divisionOther
04

Disease associations

InfectionOther
05

Safety considerations

Resistance development due to DNA sequence mutations in microbial DNATarget non-specificity: drugs may affect similar pathways in host mitochondria or commensal floraMutagenicity with some nucleic acid-targeting agents
06

Interacting drugs

Quinolones (e.g., ciprofloxacin, levofloxacin)

4 more in the full profile.

07

Biomarkers

Detection of pathogenic DNA by PCR for diagnosis of bacterial or protozoal infectionMolecular detection of resistance-associated mutations in bacterial/protozoal DNA

Beyond the preview

Go deeper on Bacterial DNA and Protozoal DNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial DNA and Protozoal DNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call